What does Dr. RIA VERVLOESEM do?

Dr. RIA VERVLOESEM is a specialist medical practice in Grobbendonk. Private Limited, started on 28 August 2000, 1 establishment.

What is the address of Dr. RIA VERVLOESEM?

The registered office of Dr. RIA VERVLOESEM is located at Heirbaan 14, 2280 Grobbendonk.

Is Dr. RIA VERVLOESEM still active?

Yes. According to the CBE (31 October 2026) Dr. RIA VERVLOESEM is active, legal situation “Normale toestand”, started on 28 August 2000.

Is Dr. RIA VERVLOESEM registered on Peppol?

Yes, Dr. RIA VERVLOESEM is registered on the Peppol network with ID 0208:0472648336.

What is the enterprise number of Dr. RIA VERVLOESEM?

The enterprise number of Dr. RIA VERVLOESEM is BE0472648336.

When was Dr. RIA VERVLOESEM founded?

Dr. RIA VERVLOESEM was founded on 28 August 2000.

Who are the directors of Dr. RIA VERVLOESEM?

According to the 2025 annual accounts, the directors of Dr. RIA VERVLOESEM are: RIA VERVLOESEM.

Is Dr. RIA VERVLOESEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 August 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. RIA VERVLOESEM make in 2025?

Dr. RIA VERVLOESEM posted a profit after taxes of € 16,178 in financial year 2025.

What is the revenue of Dr. RIA VERVLOESEM?

As a small company, Dr. RIA VERVLOESEM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,291.

Dr. RIA VERVLOESEM (Private Limited) - Grobbendonk

Dossier Dr. RIA VERVLOESEM, printed on 31 October 2026 from databakkes.be/en/0472648336/dr-ria-vervloesem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. RIA VERVLOESEM from Grobbendonk, company number BE0472648336, closed financial year 2025 with a result of € 16,178 after tax. For that financial year Dr. RIA VERVLOESEM recorded a gross margin of € 19,291 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 369,019 to € 16,178. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 1.7 million

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 16,178

▼ 96% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▲ 42% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.7 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 204

▼ 99% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 643,147 Gross margin 2022: € 643,147 First fiscal year in the series	€ 573,488 Gross margin 2023: € 573,488 ▼ 11% vs 2022 (€ 643,147) Unfavourable step	€ 444,653 Gross margin 2024: € 444,653 ▼ 22% vs 2023 (€ 573,488) Unfavourable step	€ 19,291 Gross margin 2025: € 19,291 ▼ 96% vs 2024 (€ 444,653) Unfavourable step	▼ 96%
Profit after taxes	€ 406,019 Profit after taxes 2022: € 406,019 First fiscal year in the series	€ 368,393 Profit after taxes 2023: € 368,393 ▼ 9% vs 2022 (€ 406,019) Unfavourable step	€ 369,019 Profit after taxes 2024: € 369,019 Unchanged (€ 368,393) Favourable step	€ 16,178 Profit after taxes 2025: € 16,178 ▼ 96% vs 2024 (€ 369,019) Unfavourable step	▼ 96%
Equity	€ 1,013,111 Equity 2022: € 1,013,111 First fiscal year in the series	€ 1,317,705 Equity 2023: € 1,317,705 ▲ 30% vs 2022 (€ 1,013,111) Favourable step	€ 1,686,724 Equity 2024: € 1,686,724 ▲ 28% vs 2023 (€ 1,317,705) Favourable step	€ 1,702,902 Equity 2025: € 1,702,902 ▲ 1% vs 2024 (€ 1,686,724) Favourable step	▲ 1%
Total debts	€ 325,838 Total debts 2022: € 325,838 First fiscal year in the series	€ 206,802 Total debts 2023: € 206,802 ▼ 37% vs 2022 (€ 325,838) Favourable step	€ 24,345 Total debts 2024: € 24,345 ▼ 88% vs 2023 (€ 206,802) Favourable step	€ 2,794 Total debts 2025: € 2,794 ▼ 89% vs 2024 (€ 24,345) Favourable step	▼ 89%
Cash	€ 745,418 Cash 2022: € 745,418 First fiscal year in the series	€ 915,489 Cash 2023: € 915,489 ▲ 23% vs 2022 (€ 745,418) Favourable step	€ 885,870 Cash 2024: € 885,870 ▼ 3% vs 2023 (€ 915,489) Unfavourable step	€ 1,259,757 Cash 2025: € 1,259,757 ▲ 42% vs 2024 (€ 885,870) Favourable step	▲ 42%
Land & buildings	€ 224,635 Land & buildings 2022: € 224,635 First fiscal year in the series	€ 211,257 Land & buildings 2023: € 211,257 ▼ 6% vs 2022 (€ 224,635) Unchanged	€ 211,257 Land & buildings 2024: € 211,257 Unchanged (€ 211,257) Unchanged	€ 211,257 Land & buildings 2025: € 211,257 Unchanged (€ 211,257) Unchanged
Retained profit	€ 994,511 Retained profit 2022: € 994,511 First fiscal year in the series	€ 1,299,105 Retained profit 2023: € 1,299,105 ▲ 31% vs 2022 (€ 994,511) Favourable step	€ 1,668,124 Retained profit 2024: € 1,668,124 ▲ 28% vs 2023 (€ 1,299,105) Favourable step	€ 1,684,302 Retained profit 2025: € 1,684,302 ▲ 1% vs 2024 (€ 1,668,124) Favourable step	▲ 1%
Dividend	€ 164,572 Dividend 2022: € 164,572 First fiscal year in the series	€ 63,799 Dividend 2023: € 63,799 ▼ 61% vs 2022 (€ 164,572) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 63,799) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 2,115 Bank debt 2022: € 2,115 First fiscal year in the series	€ 2,129 Bank debt 2023: € 2,129 ▲ 1% vs 2022 (€ 2,115) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 2,129) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,338,948 Balance sheet total 2022: € 1,338,948 First fiscal year in the series	€ 1,524,508 Balance sheet total 2023: € 1,524,508 ▲ 14% vs 2022 (€ 1,338,948) Unchanged	€ 1,711,069 Balance sheet total 2024: € 1,711,069 ▲ 12% vs 2023 (€ 1,524,508) Unchanged	€ 1,705,696 Balance sheet total 2025: € 1,705,696 Unchanged (€ 1,711,069) Unchanged

Key figures of Dr. RIA VERVLOESEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. RIA VERVLOESEM?

What happened at Dr. RIA VERVLOESEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 16,178 (▼ 96% vs 2024). filed late Source: NBB ↗
Sep 6, 2000 New establishment in Grobbendonk. KBO
2000 RIA VERVLOESEM became a director. NBB
Aug 28, 2000 Start of the company according to the CBE. KBO

In short

From € 406,019 profit in 2022 to € 16,178 profit in 2025.

Paid € 537,354 in corporate taxes since 2022.

Best year ever: 2022, with € 406,019 profit.

Paid out € 228,371 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

RIA VERVLOESEM

Dr. RIA VERVLOESEM

Behind Dr. RIA VERVLOESEM is RIA VERVLOESEM.

Directors

According to the 2025 annual accounts

RIA VERVLOESEM

Director

since 2000

Establishments

Establishment units

Physical locations of this company

Registered office

Heirbaan 14

2280 Grobbendonk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BEAUTY CENTER

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0472.648.336
VAT number: BE 0472.648.336
Registered office: Heirbaan 14, 2280 Grobbendonk
Names & denominations: Dr. RIA VERVLOESEM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 August 2000
Peppol: Active · Active since 11 Apr 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗